Articles On Avita Medical (ASX:AVH)

The Azure Minerals Ltd (ASX: AZS) share price is slightly higher on Friday amid a major shareholder's assertion that the junior explorer's takeover by a Chilean lithium giant appears unlikely to proceed. Azure shares are currently trading...

Mineral Resources Ltd (ASX: MIN) shares closed the session at $62.60 per share, down 0.32% amid the company hosting its annual general meeting (AGM) today. The S&P/ASX 200 Index (ASX: XJO) closed lower as well, down 0.67%. MinRes see...

ASX lithium share Mineral Resources Ltd (ASX: MIN) is trading at $60.30 per share, up 3.93% on Tuesday afternoon. Meantime, the S&P/ASX 200 Index (ASX: XJO) is up 0.89% at the time of writing. Much weaker lithium commodity prices in 2...

The Avita Medical Inc (ASX: AVH) share price is having a banner day. Shares in the ASX healthcare stock closed yesterday trading for $3.56. In morning trade on Tuesday, shares were swapping hands for $4.16, up a whopping 16.9%. After what...

The Sezzle Inc (ASX: SZL) share price is back from a trading halt and having a very tough time. In morning trade, the ASX share is crashing 27% to $11.75. Why is this ASX share crashing? Investors have been heading to the exits in their dr...

By Greg Peel Misled? The ASX200 wasted no time in falling back through 7000 on Friday triggering a -50 point fall to late morning, before calm was restored and the market went quiet through the afternoon. Wall Street’s fall provided the imp...

The ASX200 has finished the week, trading down just over half a per cent. All sectors lost ground with the utilities sector the weakest today, down about 1.7 per cent. In the green Explorer Saturn Metals (ASX:STN) is up more than 7...

The ASX has ended the week lower, down 0.55pc on Friday Healthcare Sector remains defiant  Small caps led by medtech names and Lake Johnston lithium hunters   The fickle Aussie sharemarket has given back on Friday all that it has made thi...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today. The telecommu...

All ASX sectors are trading in the red so far today – seeing the ASX200 down about half a per cent. Utilities are down the most, by about 1.5 per cent. Origin Energy (ASX:ORG) has lost 2.3 per cent so far – its future and potential takeo...

All ASX sectors are trading in the red so far today – seeing the ASX200 down about half a per cent. Utilities are down the most, by about 1.5 per cent. Origin Energy (ASX:ORG) has lost 2.3 per cent so far – its future and potential takeo...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a disappointing decline. At the time of writing, the benchmark index is down 0.55% to 6,976.4 points. Four ASX shares that are not letting that hol...

AVITA jumps after providing bullish guidance Anatara up after holding AGM this morning Imugene doses first patient in its Phase 1b clinical trial using azer-cel   AVITA up on bullish sales forecast Regenerative medicine biotech, AVITA Med...

The Magnis Energy Technologies Ltd (ASX: MNS) share price is ending the week deep in the red. At one stage today, the lithium-ion battery technology and materials company's shares were down as much as 57% to 3.5 cents. They have recovered...

The Avita Medical Inc (ASX: AVH) share price is catching the eye on Friday. In morning trade, the regenerative medicine company's shares are up 24% to $3.96. Why is the Avita Medical share price rocketing? Investors have been picking up Av...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

ASX health stocks rise in past five days in line with broader markets Mach7 Technologies reports record quarterly sales orders for Q1 FY24 Aroa maintains FY24 revenue growth forecast at 30% after strong Q2 Healthcare and life sciences exp...

The S&P ASX 200 fell -3.8% in October with mid-caps falling -6.94% and small-caps down -5.45% for the month S&P ASX 200 Energy was the only sector that closed October in the black with all Australian equity factors in red Dimerix...

Aroa Biosurgery forecasts business growth of up to 30% annually with product revenue guidance of NZ$73-$76 million in FY24 New study highlights positive outcomes using Myriad Matrix and Myriad Morcells in complex traumatic wounds Aroa focu...

ASX health sector falls in line with broader markets on macroeconomic factors and global geopolitical tensions Health imaging stock Volpara announces fourth consecutive quarter of operating cashflow Several ASX healthcare names with positi...

ASX-listed Impedimed Limited Pharmaceuticals (ASX:IDP), Avita Medical (ASX:AVH), and Neuren Pharmaceutical (ASX:NEU) lead in share price increase for 2023 while Lumos Diagnostics (ASX: LDX) tops third-quarter rankings.

ASX to open much lower after heavy selloff on Wall Street Tesla, United Airlines and Morgan Stanley tumbled Netflix jumped +12pc after posting best subscriber growth in years   Aussie shares are poised to open lower after a heavy selloff...

Stockhead’s Top 10 at shortly-before-11-ish, produced with mildly heavy heart, as I’m back from and all-too-brief break but would much rather be sitting on the riverbank fishing quietly and ignoring the rest of the world again. Top 10 highl...

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

Weekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquari...

ASX health sector falls in line with broader markets as macroeconomic factors continue to create volatility Dimerix soars on $230m licensing deal with ADVANZ PHARMA for DMX-200 into rare kidney disease US FDA approves Cyclofarm’s lung imag...

If you're wanting exposure to the energy sector this month, then Santos Ltd (ASX: STO) shares could be the way to do it. That's the view of analysts at Citi, which continue to rate the energy producer as a top option in the sector with ple...

It has been a tough day for Woodside Energy Group Ltd (ASX: WDS) and its fellow ASX energy shares. Investors have been selling off their shares today after oil prices sank during overnight trade. Here's the state of play at the time of wri...

ASX200 drops sharply on Wall Street worry Healthcare only sector to rise Small caps led by Noxopharm, Nimy Resources, Alderan and ECS Botanics   The ASX200 has inched below where it was at the start of 2023, while the Australian dollar...

The S&P/ASX 200 Index (ASX: XJO) is out of form and sinking deep into the red. In afternoon trade, the benchmark index is down 1.3% to 6,942.4 points. Four ASX shares that are falling more than most today are listed below. Here's why...

Regenerative skin restoration company AVITA Medical (ASX:AVH) has announced that its RECELL System won Best Product for the second year in a row at the Annual Meeting of the American Association for the Surgery of Trauma.

Do you want to turn $50,000 into $1 million? It sounds difficult, but long-term investing in ASX shares can help you achieve such dreams. Let's take a look at how you could go from a thousand-naire to a millionaire: Compounding magic The s...

ASX health sector fall in line with broader markets as macroeconomic factors create uncertainty Clinuvel down as its European label expansion of SCENESSE knocked back pending further data 2023 biotech market darling elevated to the S&P...

ASX healthcare stocks haven’t done so well as a collective over the past 12 months. The S&P/ASX 200 Health Care Index (ASX: XHJ) is down 8% over the past year. By comparison, the market benchmark S&P/ASX 200 Index (ASX: XJO) is u...

Weekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquari...

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

Brokers raise target prices for Avita Medical following second quarter results amidst anticipation of exciting prospects in the outlook period. -Avita Medical has beaten consensus three quarters in a row-FY24 guidance upgraded-Recell Go on...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AVH)) - Avita Medical ((BBN)) - Baby Bunting ((NCM)) - Newcrest Mining ((NWS)) - News Corp ((NCK)) - Nick Scali ((PLL)) - Piedmont Lithium ((REA)) - REA Group Check it...

ASX health stocks fall 1.82% in the past five days in line as broader markets rise slightly Resmed sinks after delivering a mixed quarterly result including margins contracting Weight loss drug frenzy drives global big pharma plays Nova No...

Futures suggest the ASX is set to open flat this morning, following news that US CPI data had risen for the first time in 13 months to 3.2 per cent. US stocks ended in the green on Wall Street, and on home soil, here are some ASX-listed...

Why do you invest in ASX shares? For many Australians, their end goal is to receive an income without working. It’s not such a crazy dream, though. It’s very realistic, in fact. For those who have managed to save up $50,000 so far, let’s e...

ASX health stocks fall 2.4% in the past five days in line with broader markets Mesoblast crashes more than 50% after US FDA rejects a key product  ImpediMed falls after calls for board spill with discontent following cap raise Healthcare...

The ASX was higher by around 2.5% in July The best sectors were Tech and Energy We look at the best and worst performing ASX stocks for the month For the month of July, most major indexes on the ASX rose by around 2.5%. Name % Change...

ASX health stocks up 1% in the past five days in line with broader markets Volpara records third quarter of positive cashflow following successful growth strategy Gut health a popular theme at 17th Bioshares Biotech Summit along with immun...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX health stocks have fallen in the past five days in line with broader markets Mach7 wins a US$60 million Veterans contract – the most significant in its history Neuren completes recruitment for Phase II trial of NNZ-2591 in Phelan-McDer...

The S&P ASX 200 was up 1.76% in June, with large caps performing the best and small caps lagging blue chips The S&P/ASX 200 Materials was the best performing sector in June, up 4.8% coming back from April drop An ASX favourite lith...

Avita Medical receives US FDA premarket approval for its RECELL System to treat vitiligo Telix will buy UK medical device firm Lightpoint Medical and its radio-guided surgery business SENSEI Antisense in strong position with new CEO, forme...

ASX-listed life science companies report a new market capitalisation of $255 billion, with Arovella Therapeutic (ASX:ALA) and Avita Medical (ASX:AVH) topping return rankings for Q1 while Neuren...